Open Access
1,2,4-Oxadiazole/2-Imidazoline Hybrids: Multi-target-directed Compounds for the Treatment of Infectious Diseases and Cancer
Тип публикации: Journal Article
Дата публикации: 2019-04-05
scimago Q1
Tоп 10% SciMago
wos Q1
white level БС1
SJR: 1.273
CiteScore: 9
Impact factor: 4.9
ISSN: 16616596, 14220067
PubMed ID:
30959765
Catalysis
Organic Chemistry
Inorganic Chemistry
Physical and Theoretical Chemistry
Computer Science Applications
Spectroscopy
Molecular Biology
General Medicine
Краткое описание
Replacement of amide moiety with the 1,2,4-oxadiazole core in the scaffold of recently reported efflux pump inhibitors afforded a novel series of oxadiazole/2-imidazoline hybrids. The latter compounds exhibited promising antibacterial activity on both Gram-positive (Staphylococcus aureus, Bacillus subtilis) and Gram-negative (Escherichia coli, Pseudomonas fluorescens) strains. Furthermore, selected compounds markedly inhibited the growth of certain drug-resistant bacteria. Additionally, the study revealed the antiproliferative activity of several antibacterial frontrunners against pancreas ductal adenocarcinoma (PANC-1) cell line, as well as their type-selective monoamine oxidase (MAO) inhibitory profile.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
1
2
3
4
|
|
|
Tetrahedron Letters
4 публикации, 10.81%
|
|
|
Molecules
4 публикации, 10.81%
|
|
|
Russian Journal of General Chemistry
4 публикации, 10.81%
|
|
|
Molecular Diversity
3 публикации, 8.11%
|
|
|
International Journal of Molecular Sciences
3 публикации, 8.11%
|
|
|
Russian Journal of Organic Chemistry
2 публикации, 5.41%
|
|
|
ChemistrySelect
2 публикации, 5.41%
|
|
|
European Journal of Organic Chemistry
1 публикация, 2.7%
|
|
|
Journal of Molecular Structure
1 публикация, 2.7%
|
|
|
Inorganics
1 публикация, 2.7%
|
|
|
Pharmaceuticals
1 публикация, 2.7%
|
|
|
Medicinal Chemistry Research
1 публикация, 2.7%
|
|
|
Bioorganic and Medicinal Chemistry Letters
1 публикация, 2.7%
|
|
|
Immunopharmacology and Immunotoxicology
1 публикация, 2.7%
|
|
|
RSC Advances
1 публикация, 2.7%
|
|
|
Asian Journal of Chemistry
1 публикация, 2.7%
|
|
|
Letters in Drug Design and Discovery
1 публикация, 2.7%
|
|
|
Synthesis
1 публикация, 2.7%
|
|
|
Журнал Общей Химии
1 публикация, 2.7%
|
|
|
Inorganica Chimica Acta
1 публикация, 2.7%
|
|
|
Journal of the Turkish Chemical Society, Section A: Chemistry
1 публикация, 2.7%
|
|
|
1
2
3
4
|
Издатели
|
1
2
3
4
5
6
7
8
9
|
|
|
MDPI
9 публикаций, 24.32%
|
|
|
Elsevier
7 публикаций, 18.92%
|
|
|
Pleiades Publishing
7 публикаций, 18.92%
|
|
|
Springer Nature
4 публикации, 10.81%
|
|
|
Wiley
3 публикации, 8.11%
|
|
|
Taylor & Francis
1 публикация, 2.7%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 2.7%
|
|
|
Asian Journal of Chemistry
1 публикация, 2.7%
|
|
|
Bentham Science Publishers Ltd.
1 публикация, 2.7%
|
|
|
Georg Thieme Verlag KG
1 публикация, 2.7%
|
|
|
Turkish Chemical Society
1 публикация, 2.7%
|
|
|
1
2
3
4
5
6
7
8
9
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
37
Всего цитирований:
37
Цитирований c 2025:
2
(5.41%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Shetnev A. et al. 1,2,4-Oxadiazole/2-Imidazoline Hybrids: Multi-target-directed Compounds for the Treatment of Infectious Diseases and Cancer // International Journal of Molecular Sciences. 2019. Vol. 20. No. 7. p. 1699.
ГОСТ со всеми авторами (до 50)
Скопировать
Shetnev A., Baykov S., Kalinin S., Belova A., Sharoyko V., Rozhkov A., Zelenkov L., Tarasenko M., Sadykov E., Korsakov M., Krasavin M. 1,2,4-Oxadiazole/2-Imidazoline Hybrids: Multi-target-directed Compounds for the Treatment of Infectious Diseases and Cancer // International Journal of Molecular Sciences. 2019. Vol. 20. No. 7. p. 1699.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.3390/IJMS20071699
UR - https://doi.org/10.3390/IJMS20071699
TI - 1,2,4-Oxadiazole/2-Imidazoline Hybrids: Multi-target-directed Compounds for the Treatment of Infectious Diseases and Cancer
T2 - International Journal of Molecular Sciences
AU - Shetnev, Anton
AU - Baykov, Sergey
AU - Kalinin, Stanislav
AU - Belova, Alexandra
AU - Sharoyko, Vladimir
AU - Rozhkov, Anton
AU - Zelenkov, Lev
AU - Tarasenko, Marina
AU - Sadykov, Evgeny
AU - Korsakov, Mikhail
AU - Krasavin, Mikhail
PY - 2019
DA - 2019/04/05
PB - MDPI
SP - 1699
IS - 7
VL - 20
PMID - 30959765
SN - 1661-6596
SN - 1422-0067
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2019_Shetnev,
author = {Anton Shetnev and Sergey Baykov and Stanislav Kalinin and Alexandra Belova and Vladimir Sharoyko and Anton Rozhkov and Lev Zelenkov and Marina Tarasenko and Evgeny Sadykov and Mikhail Korsakov and Mikhail Krasavin},
title = {1,2,4-Oxadiazole/2-Imidazoline Hybrids: Multi-target-directed Compounds for the Treatment of Infectious Diseases and Cancer},
journal = {International Journal of Molecular Sciences},
year = {2019},
volume = {20},
publisher = {MDPI},
month = {apr},
url = {https://doi.org/10.3390/IJMS20071699},
number = {7},
pages = {1699},
doi = {10.3390/IJMS20071699}
}
Цитировать
MLA
Скопировать
Shetnev, Anton, et al. “1,2,4-Oxadiazole/2-Imidazoline Hybrids: Multi-target-directed Compounds for the Treatment of Infectious Diseases and Cancer.” International Journal of Molecular Sciences, vol. 20, no. 7, Apr. 2019, p. 1699. https://doi.org/10.3390/IJMS20071699.
Ошибка в публикации?